Anti-IL-25 antibodies and use thereof
US12258392B2 · kind B2 · utility
0Cited by
0References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 19, 2018 |
| Grant date | Mar 25, 2025 |
| Priority date | — |
| Expiry date | Jul 14, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides anti-IL-25 antibodies that are directed against (human) IL-25, nucleic acids that encode such antibodies, compositions, and in particular pharmaceutical compositions that comprise such antibodies; and uses of such antibodies and compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.